Minerva Net Income From Continuing Ops from 2010 to 2026
| NERV Stock | USD 6.27 0.02 0.32% |
Net Income From Continuing Ops | First Reported 2012-12-31 | Previous Quarter -3.3 M | Current Value -2.7 M | Quarterly Volatility 11.5 M |
Check Minerva Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Minerva Neurosciences' main balance sheet or income statement drivers, such as Other Operating Expenses of 34.5 M, Research Development of 23.6 M or EBITDA of 5.7 M, as well as many indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Minerva financial statements analysis is a perfect complement when working with Minerva Neurosciences Valuation or Volatility modules.
Minerva | Net Income From Continuing Ops | Build AI portfolio with Minerva Stock |
The evolution of Net Income From Continuing Ops for Minerva Neurosciences provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Minerva Neurosciences compares to historical norms and industry peers.
Latest Minerva Neurosciences' Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Minerva Neurosciences over the last few years. It is Minerva Neurosciences' Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Minerva Neurosciences' overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Minerva Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | (35,262,588) | |
| Coefficient Of Variation | (70.08) | |
| Mean Deviation | 20,549,084 | |
| Median | (32,108,676) | |
| Standard Deviation | 24,710,478 | |
| Sample Variance | 610.6T | |
| Range | 74.1M | |
| R-Value | 0.72 | |
| Mean Square Error | 316.7T | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 3,507,398 | |
| Total Sum of Squares | 9769.7T |
Minerva Net Income From Continuing Ops History
About Minerva Neurosciences Financial Statements
Minerva Neurosciences investors use historical fundamental indicators, such as Minerva Neurosciences' Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Minerva Neurosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 1.7 M | 1.7 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.